Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
2.2
Journals
Pharmacy
Special Issues
Medication Use of Patients in Hemodialysis Patients
share announcement

Medication Use of Patients in Hemodialysis Patients

A special issue of Pharmacy (ISSN 2226-4787).

Deadline for manuscript submissions: closed (31 July 2021) | Viewed by 3252

Special Issue Editor

Dr. Marisa Battistella

E-Mail Website
Guest Editor
Department of Pharmacy, University Health Network, Leslie Dan Faculty of Pharmacy University of Toronto, Toronto, ON M4G 2C4, Canada
Interests: medication optimization in chronic kidney disease

Special Issue Information

Dear Colleagues,

Polypharmacy refers to the use of multiple concurrent medications, typically five or more per day. Consequences of polypharmacy can be numerous and drastic. These include adverse drug reactions, drug–drug interactions, non-adherence, increased risk of cognitive impairment, impaired balance, and falls; and finally, an increased risk of morbidity, hospitalization, and mortality by greater than 45%.2-Patients on hemodialysis (HD) have the highest pill burden of all chronically ill patient populations, taking on average 12 + 5 distinct medications per day.

We invite you to share your approaches and successes in understanding and improving medication use in patients on hemodialysis. We hope this Special Issue will inspire other clinicians to share their own practices, adopt new approaches, and innovate to help patients on hemodialysis manage their medications.

Prof. Dr. Marisa Battistella
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • medication use
  • medication optimization
  • deprescribing
  • chronic kidney disease
  • hemodialysis

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

13 pages, 3012 KiB  
Article
Evaluation of a Pharmacist–Dietician-Led Patient-Centered Approach to Managing CKD-MBD: A Mixed-Method Study
by Tamara Baker, Heather Naylor, Bryanne MacNeil and Martin MacKinnon
Pharmacy 2020, 8(3), 171; https://doi.org/10.3390/pharmacy8030171 - 14 Sep 2020
Cited by 2 | Viewed by 2794
Abstract
Chronic kidney disease mineral and bone disorder (CKD-MBD) is a common complication in end-stage renal disease (ESRD). To improve prescribing consistency and patient outcomes, a patient-centered, pharmacist–dietician-led approach to managing CKD-MBD was developed. The purpose of this study was to evaluate if the [...] Read more.
Chronic kidney disease mineral and bone disorder (CKD-MBD) is a common complication in end-stage renal disease (ESRD). To improve prescribing consistency and patient outcomes, a patient-centered, pharmacist–dietician-led approach to managing CKD-MBD was developed. The purpose of this study was to evaluate if the new approach impacted serum markers of CKD-MBD and medication burden, and to evaluate patient satisfaction. A single-arm, pre–post, mixed-methods study was conducted. Serum markers of CKD-MBD and medication data were collected pre- and post-intervention, and a patient survey administered post-intervention. Focus groups were conducted, transcribed, and analyzed thematically. No statistically significant differences in serum markers of CKD-MBD or medication burden were found. Eighty-seven percent of patients were satisfied with their care, however, 31% were very dissatisfied with medical explanations provided to them and 48% felt their allotted time with healthcare professionals was too short. Four major themes identified from focus groups included lack of privacy, knowledge and perceptions of blood work rounds, issues with taking phosphate binders, and areas for increased patient education. Patients would prefer more information regarding their blood work results and more time with the healthcare team. Areas for expanded education include renal diet, phosphate binders, and consequences of abnormal bloodwork. Full article
(This article belongs to the Special Issue Medication Use of Patients in Hemodialysis Patients)
►▼ Show Figures

Figure A1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop